InsiderClue

Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 1/25
WGS
Result 261 decisions over 120 months
Reset filters
Direction ?
Both261 Bought39 Sold222
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo 120 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Company: WGS
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
WGS GeneDx Holdings Corp.
29 Oct 2024
Stueland Katherine
Chief Executive Officer
Sold at will
2,154
$143.46K
2.0%
WGS GeneDx Holdings Corp.
29 Oct 2024
Feeley Kevin
CHIEF FINANCIAL OFFICER
Sold at will
274
$18.25K
0.6%
WGS GeneDx Holdings Corp.
16 Sep 2024
Stueland Katherine
Chief Executive Officer
Sold at will
10,501
$394.73K
9.2%
WGS GeneDx Holdings Corp.
16 Sep 2024
Feeley Kevin
CHIEF FINANCIAL OFFICER
Sold at will
2,635
$99.05K
5.6%
WGS GeneDx Holdings Corp.
9 Sep 2024
Stueland Katherine
Chief Executive Officer
Sold at will
3,639
$121.29K
3.7%
WGS GeneDx Holdings Corp.
9 Sep 2024
Feeley Kevin
CHIEF FINANCIAL OFFICER
Sold at will
895
$29.83K
2.2%
WGS GeneDx Holdings Corp.
3 Sep 2024
Feeley Kevin
CHIEF FINANCIAL OFFICER
Sold at will
262
$8.31K
0.7%
WGS GeneDx Holdings Corp.
19 Aug 2024
OPKO HEALTH, INC.
10% owner
Sold at will
50,000
$1.72M
1.9%
WGS GeneDx Holdings Corp.
16 Aug 2024
OPKO HEALTH, INC.
10% owner
Sold at will
50,000
$1.71M
1.8%
WGS GeneDx Holdings Corp.
15 Aug 2024
OPKO HEALTH, INC.
10% owner
Sold at will
39,824
$1.32M
1.4%
WGS GeneDx Holdings Corp.
13 Aug 2024
OPKO HEALTH, INC.
10% owner
Sold at will
24,987
$868.50K
0.9%
WGS GeneDx Holdings Corp.
12 Aug 2024
OPKO HEALTH, INC.
10% owner
Sold at will
59,787
$2.03M
2.1%
WGS GeneDx Holdings Corp.
8 Aug 2024
OPKO HEALTH, INC.
10% owner
Sold at will
100,000
$3.18M
3.4%
WGS GeneDx Holdings Corp.
6 Aug 2024
OPKO HEALTH, INC.
10% owner
Sold at will
12,994
$381.43K
0.4%
WGS GeneDx Holdings Corp.
31 Jul 2024
OPKO HEALTH, INC.
10% owner
Sold at will
88,839
$2.98M
2.9%
WGS GeneDx Holdings Corp.
29 Jul 2024
OPKO HEALTH, INC.
10% owner
Sold at will
50,000
$1.69M
1.6%
WGS GeneDx Holdings Corp.
29 Jul 2024
Stueland Katherine
Chief Executive Officer
Sold at will
2,154
$72.25K
2.3%
WGS GeneDx Holdings Corp.
29 Jul 2024
Feeley Kevin
CHIEF FINANCIAL OFFICER
Sold at will
274
$9.19K
0.7%
WGS GeneDx Holdings Corp.
26 Jul 2024
OPKO HEALTH, INC.
10% owner
Sold at will
60,000
$2.03M
1.9%
WGS GeneDx Holdings Corp.
24 Jul 2024
OPKO HEALTH, INC.
10% owner
Sold at will
75,000
$2.53M
2.3%
WGS GeneDx Holdings Corp.
23 Jul 2024
OPKO HEALTH, INC.
10% owner
Sold at will
75,000
$2.51M
2.3%
WGS GeneDx Holdings Corp.
22 Jul 2024
OPKO HEALTH, INC.
10% owner
Sold at will
50,000
$1.63M
1.5%
WGS GeneDx Holdings Corp.
19 Jul 2024
OPKO HEALTH, INC.
10% owner
Sold at will
25,000
$807.25K
0.7%
WGS GeneDx Holdings Corp.
17 Jul 2024
OPKO HEALTH, INC.
10% owner
Sold at will
25,000
$823.19K
0.7%
WGS GeneDx Holdings Corp.
5 Jul 2024
OPKO HEALTH, INC.
10% owner
Sold at will
36,118
$1.02M
1.0%
WGS GeneDx Holdings Corp.
3 Jul 2024
OPKO HEALTH, INC.
10% owner
Sold on a plan
14,082
$397.49K
0.4%
WGS GeneDx Holdings Corp.
2 Jul 2024
OPKO HEALTH, INC.
10% owner
Sold on a plan
25,000
$728.10K
0.7%
WGS GeneDx Holdings Corp.
1 Jul 2024
OPKO HEALTH, INC.
10% owner
Sold on a plan
50,000
$1.33M
1.4%
WGS GeneDx Holdings Corp.
17 Jun 2024
Stueland Katherine
Chief Executive Officer
Sold at will
7,683
$217.51K
7.8%
WGS GeneDx Holdings Corp.
17 Jun 2024
Feeley Kevin
CHIEF FINANCIAL OFFICER
Sold at will
2,646
$74.91K
6.6%
WGS GeneDx Holdings Corp.
10 Jun 2024
Stueland Katherine
Chief Executive Officer
Sold at will
2,652
$66.09K
3.2%
WGS GeneDx Holdings Corp.
10 Jun 2024
Feeley Kevin
CHIEF FINANCIAL OFFICER
Sold at will
895
$22.30K
2.7%
WGS GeneDx Holdings Corp.
4 Jun 2024
Casdin Capital, LLC
Director
Bought
30,000
$675.48K
1.0%
WGS GeneDx Holdings Corp.
3 Jun 2024
Casdin Capital, LLC
Director
Bought
100,000
$2.08M
3.4%
WGS GeneDx Holdings Corp.
3 Jun 2024
Feeley Kevin
CHIEF FINANCIAL OFFICER
Sold at will
262
$5.38K
0.8%
WGS GeneDx Holdings Corp.
29 May 2024
Casdin Capital, LLC
Director
Bought
40,000
$842.60K
1.4%
WGS GeneDx Holdings Corp.
28 May 2024
Casdin Capital, LLC
Director
Bought
18,304
$377.17K
0.6%
WGS GeneDx Holdings Corp.
24 May 2024
Casdin Capital, LLC
Director
Bought
144,196
$2.90M
5.2%
WGS GeneDx Holdings Corp.
23 May 2024
Casdin Capital, LLC
Director
Bought
7,500
$146.92K
0.3%
WGS GeneDx Holdings Corp.
13 May 2024
Casdin Capital, LLC
Director
Bought
50,000
$1.17M
1.8%
WGS GeneDx Holdings Corp.
29 Apr 2024
Stueland Katherine
Chief Executive Officer
Sold at will
6,325
$69.81K
7.7%
WGS GeneDx Holdings Corp.
29 Apr 2024
Feeley Kevin
CHIEF FINANCIAL OFFICER
Sold at will
1,104
$12.18K
3.5%
WGS GeneDx Holdings Corp.
18 Mar 2024
Stueland Katherine
CHIEF EXECUTIVE OFFICER
Sold at will
8,559
$90.66K
11.4%
WGS GeneDx Holdings Corp.
18 Mar 2024
Feeley Kevin
CHIEF FINANCIAL OFFICER
Sold at will
3,253
$34.45K
10.1%
WGS GeneDx Holdings Corp.
18 Mar 2024
Saad Kareem
CHIEF TRANSFORMATION OFFICER
Sold at will
2,008
$21.27K
6.4%
WGS GeneDx Holdings Corp.
12 Mar 2024
Stueland Katherine
CHIEF EXECUTIVE OFFICER
Sold at will
2,618
$24.11K
4.4%
WGS GeneDx Holdings Corp.
12 Mar 2024
Feeley Kevin
CHIEF FINANCIAL OFFICER
Sold at will
931
$8.57K
3.6%
WGS GeneDx Holdings Corp.
12 Mar 2024
Saad Kareem
CHIEF TRANSFORMATION OFFICER
Sold at will
897
$8.26K
3.3%
WGS GeneDx Holdings Corp.
5 Mar 2024
Casdin Capital, LLC
Director
Bought
900
$7.94K
0.0%
WGS GeneDx Holdings Corp.
4 Mar 2024
Casdin Capital, LLC
Director
Bought
40,000
$349.71K
1.5%
Showing 101–150 of 261. ← Newer Page 3 of 6 Older →